News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
353,738 Results
Type
Article (20511)
Company Profile (142)
Press Release (333080)
Multimedia
Podcasts (72)
Webinars (13)
Section
Business (108115)
Career Advice (732)
Deals (25260)
Drug Delivery (83)
Drug Development (43240)
Employer Resources (66)
FDA (8173)
Job Trends (8249)
News (189235)
Policy (17606)
Tag
Academia (843)
Accelerated approval (9)
Adcomms (9)
Allergies (66)
Alliances (28484)
ALS (75)
Alzheimer's disease (627)
Antibody-drug conjugate (ADC) (147)
Approvals (8355)
Artificial intelligence (303)
Autoimmune disease (46)
Automation (15)
Bankruptcy (194)
Best Places to Work (6029)
BIOSECURE Act (10)
Biosimilars (111)
Biotechnology (66)
Bladder cancer (44)
Brain cancer (35)
Breast cancer (219)
Cancer (1796)
Cardiovascular disease (188)
Career advice (646)
Career pathing (19)
CAR-T (86)
CDC (9)
Cell therapy (244)
Cervical cancer (18)
Clinical research (37315)
Collaboration (852)
Company closure (1)
Compensation (337)
Complete response letters (35)
COVID-19 (1119)
CRISPR (48)
C-suite (401)
Cystic fibrosis (67)
Data (2356)
Denatured (18)
Depression (50)
Diabetes (198)
Diagnostics (2459)
Digital health (22)
Diversity (4)
Diversity, equity & inclusion (21)
Drug discovery (143)
Drug pricing (119)
Drug shortages (15)
Duchenne muscular dystrophy (88)
Earnings (42572)
Editorial (23)
Employer branding (6)
Employer resources (61)
Events (46598)
Executive appointments (608)
FDA (9564)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (3)
Frontotemporal dementia (9)
Funding (576)
Gene editing (88)
Generative AI (25)
Gene therapy (237)
GLP-1 (567)
Government (1898)
Grass and pollen (4)
Guidances (250)
Healthcare (6443)
HIV (26)
Huntington's disease (9)
IgA nephropathy (47)
Immunology and inflammation (90)
Immuno-oncology (11)
Indications (43)
Infectious disease (1218)
Inflammatory bowel disease (94)
Inflation Reduction Act (7)
Influenza (39)
Intellectual property (129)
Interviews (110)
IPO (8120)
IRA (39)
Job creations (2478)
Job search strategy (555)
Kidney cancer (9)
Labor market (34)
Layoffs (303)
Leadership (12)
Legal (4457)
Liver cancer (35)
Longevity (10)
Lung cancer (273)
Lymphoma (157)
Machine learning (17)
Management (21)
Manufacturing (438)
MASH (85)
Medical device (4054)
Medtech (4067)
Mergers & acquisitions (17889)
Metabolic disorders (566)
Multiple sclerosis (64)
NASH (14)
Neurodegenerative disease (107)
Neuropsychiatric disorders (37)
Neuroscience (1140)
NextGen: Class of 2025 (2609)
Non-profit (1253)
Now hiring (17)
Obesity (276)
Opinion (175)
Ovarian cancer (41)
Pain (107)
Pancreatic cancer (68)
Parkinson's disease (101)
Partnered (15)
Patents (252)
Patient recruitment (139)
Peanut (16)
People (34147)
Pharmaceutical (69)
Pharmacy benefit managers (19)
Phase I (9983)
Phase II (15920)
Phase III (13981)
Pipeline (1928)
Policy (141)
Postmarket research (1571)
Preclinical (4168)
Press Release (28)
Prostate cancer (103)
Psychedelics (17)
Radiopharmaceuticals (156)
Rare diseases (375)
Real estate (3242)
Recruiting (24)
Regulatory (13198)
Reports (25)
Research institute (902)
Resumes & cover letters (108)
Rett syndrome (18)
RNA editing (7)
RSV (29)
Schizophrenia (91)
Series A (110)
Series B (65)
Service/supplier (5)
Sickle cell disease (50)
Special edition (13)
Spinal muscular atrophy (93)
Sponsored (15)
Startups (2138)
State (2)
Stomach cancer (5)
Supply chain (57)
Tariffs (70)
The Weekly (52)
Vaccines (368)
Venture capital (37)
Weight loss (184)
Women's health (27)
Worklife (5)
Date
Last 7 days (186)
Last 30 days (1554)
Last 365 days (15561)
2025 (14485)
2024 (17245)
2023 (19097)
2022 (26261)
2021 (27155)
2020 (25752)
2019 (21112)
2018 (16702)
2017 (17732)
2016 (16592)
2015 (19402)
2014 (15359)
2013 (13027)
2012 (13921)
2011 (14539)
2010 (13303)
Location
Africa (420)
Alabama (24)
Alaska (2)
Arizona (104)
Arkansas (6)
Asia (25145)
Australia (3378)
California (4098)
Canada (1708)
China (570)
Colorado (177)
Connecticut (205)
Delaware (156)
Europe (51662)
Florida (722)
Georgia (109)
Hawaii (2)
Idaho (22)
Illinois (388)
India (41)
Indiana (291)
Iowa (3)
Japan (251)
Kansas (81)
Kentucky (24)
Louisiana (15)
Maine (12)
Maryland (542)
Massachusetts (3248)
Michigan (93)
Minnesota (189)
Mississippi (1)
Missouri (53)
Montana (12)
Nebraska (8)
Nevada (31)
New Hampshire (20)
New Jersey (1703)
New Mexico (10)
New York (1178)
North Carolina (798)
North Dakota (4)
Northern California (1789)
Ohio (121)
Oklahoma (6)
Oregon (20)
Pennsylvania (986)
Puerto Rico (14)
Rhode Island (22)
South America (664)
South Carolina (17)
Southern California (1733)
Tennessee (114)
Texas (582)
United States (16323)
Utah (96)
Vermont (1)
Virginia (159)
Washington D.C. (49)
Washington State (309)
West Virginia (3)
Wisconsin (51)
Wyoming (1)
353,738 Results for "arcutis pharmaceuticals acquired by valeant pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Arcutis to Present at Upcoming November 2025 Investor Conferences
October 28, 2025
·
2 min read
Press Releases
Harrow to Acquire Melt Pharmaceuticals
September 29, 2025
·
8 min read
Press Releases
Arcutis Outlines Strategy for Driving Sustainable Growth and Announces Third Quarter 2025 Financial Results
October 29, 2025
·
10 min read
Press Releases
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 7, 2025
November 10, 2025
·
2 min read
Press Releases
Rhythm Pharmaceuticals Announces FDA Extension of Review Period for IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity
November 10, 2025
·
8 min read
Press Releases
Arcutis Completes Enrollment in INTEGUMENT-INFANT Phase 2 Study Evaluating ZORYVE® (roflumilast) Cream 0.05% in Infants with Atopic Dermatitis
November 14, 2025
·
7 min read
Press Releases
Rhythm Pharmaceuticals Announces FDA Acceptance of sNDA for Setmelanotide in Acquired Hypothalamic Obesity
August 21, 2025
·
13 min read
Press Releases
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 3, 2025
October 5, 2025
·
2 min read
Press Releases
FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children Ages 2 to 5
November 18, 2025
·
6 min read
Press Releases
Arcutis Biotherapeutics to Host Virtual Investor Day and Report Third Quarter 2025 Financial Results on October 28, 2025
September 29, 2025
·
3 min read
1 of 35,374
Next
